×
About 3,776 results

ALLMedicine™ Hypoparathyroidism Center

Research & Reviews  1,657 results

Therapy with PTH 1-34 or Calcitriol and Calcium in Diverse Etiologies of Hypoparathyroi...
https://doi.org/10.1016/j.bone.2021.115977
Bone Winer KK, Ye S et. al.

May 1st, 2021 - Hypoparathyroidism has heterogeneous genetic and acquired etiologies with a broad spectrum of severity. Herein we describe the clinical outcomes of the largest cohort of hypoparathyroid patients reported to date, who were followed over 27-years. P...

Near-infrared autofluorescence imaging may reduce temporary hypoparathyroidism in patie...
https://doi.org/10.1089/thy.2021.0056
Thyroid : Official Journal of the American Thyroid Associ... Kim DH, Kim SW et. al.

Apr 28th, 2021 - Near-infrared autofluorescence (NIRAF) imaging is known to reduce the incidence of post-thyroidectomy hypocalcemia. However, there are no studies on how much NIRAF imaging affects the serum parathyroid hormone (PTH) level after surgery. We investi...

Short-term recovery in patients suffering hypoparathyroid after thyroidectomy: a case c...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059228
BMC Surgery; Su D, Xia F et. al.

Apr 22nd, 2021 - Postoperative hypoparathyroidism is the main reason for outpatient follow-up and long-term oral calcium and calcitriol treatment. Our study investigated the influencing factors and powerful predictors of short-term postoperative parathyroid functi...

The Antiresorptive Effect of GIP, But Not GLP-2, Is Preserved in Patients With Hypopara...
https://doi.org/10.1002/jbmr.4308
Journal of Bone and Mineral Research : the Official Journ... Skov-Jeppesen K, Hepp N et. al.

Apr 14th, 2021 - Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2) are gut hormones secreted postprandially. In healthy humans, both hormones decrease bone resorption accompanied by a rapid reduction in parathyroid hormone (PTH...

Protective strategy of parathyroid glands during thyroid lobectomy: A retrospective coh...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036091
Medicine Xing Z, Qiu Y et. al.

Apr 9th, 2021 - Parathyroid protection during thyroid lobectomy was not illustrated previously. Aim of this study was to find out the influence of parathyroid glands in situ preservation and autotransplantation on postoperative parathyroid function in thyroid lob...

see more →

Guidelines  5 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, ...
https://doi.org/10.1089/thy.2017.0309
Thyroid : Official Journal of the American Thyroid Associ... Orloff LA, Wiseman SM et. al.

May 31st, 2018 - Hypoparathyroidism (hypoPT) is the most common complication following bilateral thyroid operations. Thyroid surgeons must employ strategies for minimizing and preventing post-thyroidectomy hypoPT. The objective of this American Thyroid Association...

Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian ...
https://doi.org/10.20945/2359-3997000000015
Archives of Endocrinology and Metabolism; Maeda SS, Moreira CA et. al.

Apr 25th, 2018 - Objective To present an update on the diagnosis and treatment of hypoparathyroidism based on the most recent scientific evidence. Materials and methods The Department of Bone and Mineral Metabolism of the Sociedade Brasileira de Endocrinologia e M...

European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyr...
https://doi.org/10.1530/EJE-15-0628
European Journal of Endocrinology; Bollerslev J, Rejnmark L et. al.

Jul 14th, 2015 - Hypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately low (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment is activated vit...

Clinical practice guideline: improving voice outcomes after thyroid surgery.
https://doi.org/10.1177/0194599813487301
Otolaryngology--head and Neck Surgery : Official Journal ... Chandrasekhar SS, Randolph GW et. al.

Jun 13th, 2013 - Thyroidectomy may be performed for clinical indications that include malignancy, benign nodules or cysts, suspicious findings on fine needle aspiration biopsy, dysphagia from cervical esophageal compression, or dyspnea from airway compression. Abo...

see more →

Drugs  119 results see all →

Clinicaltrials.gov  1,877 results

Therapy with PTH 1-34 or Calcitriol and Calcium in Diverse Etiologies of Hypoparathyroi...
https://doi.org/10.1016/j.bone.2021.115977
Bone Winer KK, Ye S et. al.

May 1st, 2021 - Hypoparathyroidism has heterogeneous genetic and acquired etiologies with a broad spectrum of severity. Herein we describe the clinical outcomes of the largest cohort of hypoparathyroid patients reported to date, who were followed over 27-years. P...

Near-infrared autofluorescence imaging may reduce temporary hypoparathyroidism in patie...
https://doi.org/10.1089/thy.2021.0056
Thyroid : Official Journal of the American Thyroid Associ... Kim DH, Kim SW et. al.

Apr 28th, 2021 - Near-infrared autofluorescence (NIRAF) imaging is known to reduce the incidence of post-thyroidectomy hypocalcemia. However, there are no studies on how much NIRAF imaging affects the serum parathyroid hormone (PTH) level after surgery. We investi...

Short-term recovery in patients suffering hypoparathyroid after thyroidectomy: a case c...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059228
BMC Surgery; Su D, Xia F et. al.

Apr 22nd, 2021 - Postoperative hypoparathyroidism is the main reason for outpatient follow-up and long-term oral calcium and calcitriol treatment. Our study investigated the influencing factors and powerful predictors of short-term postoperative parathyroid functi...

The Antiresorptive Effect of GIP, But Not GLP-2, Is Preserved in Patients With Hypopara...
https://doi.org/10.1002/jbmr.4308
Journal of Bone and Mineral Research : the Official Journ... Skov-Jeppesen K, Hepp N et. al.

Apr 14th, 2021 - Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2) are gut hormones secreted postprandially. In healthy humans, both hormones decrease bone resorption accompanied by a rapid reduction in parathyroid hormone (PTH...

Protective strategy of parathyroid glands during thyroid lobectomy: A retrospective coh...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036091
Medicine Xing Z, Qiu Y et. al.

Apr 9th, 2021 - Parathyroid protection during thyroid lobectomy was not illustrated previously. Aim of this study was to find out the influence of parathyroid glands in situ preservation and autotransplantation on postoperative parathyroid function in thyroid lob...

see more →

News  113 results

Natpar(a): A Case in Point for Rare Disease Drugs?
https://www.staging.medscape.com/viewarticle/922834

Dec 17th, 2019 - While the recent recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States has grabbed the headlines, the situation for patients with chronic hypoparathyroidism who want to take the drug in Europe (where it'...

Natpar(a): A Case in Point for Rare Disease Drugs?
https://www.medscape.com/viewarticle/922834

Dec 17th, 2019 - While the recent recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States has grabbed the headlines, the situation for patients with chronic hypoparathyroidism who want to take the drug in Europe (where it'...

Drug Recall in US Causes Hypoparathyroid Patients Extreme Hardship
https://www.medscape.com/viewarticle/921971

Dec 1st, 2019 - The recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States over safety concerns about the product is gravely affecting the lives of American patients with severe hypoparathyroidism who need replacement PT...

Parathyroid Hormone Replacement Effective, Safe Long Term
https://www.staging.medscape.com/viewarticle/911357

Apr 3rd, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...

Parathyroid Hormone Replacement Effective, Safe Long Term
https://www.medscape.com/viewarticle/911357

Apr 3rd, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...

see more →

Patient Education  5 results see all →